As of my last update in October 2023, specific information regarding the chemical substance CTA056, with the CAS number 1265822-30-7, is limited in publicly available databases. Generally, substances with such identifiers are often in the realm of research chemicals or pharmaceuticals, and their characteristics can include molecular structure, solubility, stability, and biological activity, among others. Typically, detailed information would encompass aspects like melting and boiling points, density, and potential applications in various fields such as medicinal chemistry or materials science. For precise characteristics, including safety data, handling procedures, and regulatory status, consulting specialized databases, scientific literature, or safety data sheets (SDS) would be essential. If CTA056 is a compound of interest, further investigation through academic publications or chemical suppliers may yield more comprehensive insights into its properties and uses.

CTA056

Find at CymitQuimica all products linked to CAS 1265822-30-7. Enter now to get more information

CTA 056 is an inhibitor of the ubiquitin proteasome that has been shown to suppress the expression of suppressor genes. It has been shown to inhibit the proliferation of estrogen receptor-positive breast cancer cells. CTA 056 also inhibits the proliferation of T-cell lymphomas, specifically in vitro and in vivo models. This drug targets a molecule that is important for cell cycle regulation, CDK4/6, by binding to it and inhibiting its activity. In addition, CTA 056 binds to other molecules such as protein kinases and may have potential as a molecular target for new cancer drugs.

CTA 056

CTA 056 is an ITK inhibitor that inhibits the growth of MOLT-4 xenograft tumors in mice and can be used to study autoimmune disorders.

CAS 1265822-30-7: CTA056

CTA 056

Ref: 3D-QAC82230

CTA 056

Ref: TM-T35569

CTA 056

Ref: 54-BUP02351